pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
about
Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome.Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer's disease.Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.Alzheimer's Disease, Oligomers, and Inflammation.
P2860
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@en
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@nl
type
label
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@en
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@nl
prefLabel
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@en
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@nl
P2093
P2860
P1476
pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
@en
P2093
Inge Snoeren
Mobina Khericha
Oyinkan Sofola-Adesakin
P2860
P2888
P356
10.1186/S40478-016-0380-X
P577
2016-10-07T00:00:00Z
P6179
1035353333